In light of recent developments in the hemp-CBD space, AHPA revised its Status Report: Marketing of hemp and cannabidiol (CBD) products in the United States, as of April 2020.
Photo © iStockphoto.com/AlenaPaulus
The regulatory landscape of hemp and hemp-derived CBD is constantly evolving, which can make it difficult to keep up with. That is why the American Herbal Products Association (AHPA; Silver Springs, MD) has created and continues to update its free Hemp-CBD Status Report. In light of recent developments in the hemp-CBD space, AHPA revised its Status Report: Marketing of hemp and cannabidiol (CBD) products in the United States, as of April 2020.
The revisions to the report cover the U.S. Department of Agriculture’s (USDA) Interim Final Rule, issued in October 2019, as well as additional USDA updates since then, including two portions of the interim final rule for which the agency will be implementing enforcement discretion. The revised report also informs growers about what to be aware of for the 2020 growing season, and contains the latest U.S. Food and Drug Administration (FDA) developments since the report was last issued. These FDA developments include warning letters, a consumer update issued in October 2019, the March 2020 FDA report to Congress on CBD regulation, and consideration of potential legislative options.
The report can be downloaded for free here.